APA (7th ed.) Citation

Medina, J., Khunti, K., Pintat, S., Fenici, P., Hammar, N., Ji, L., . . . Surmont, F. Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: A global perspective from the DISCOVER study. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Medina, Jesús, Kamlesh Khunti, Stéphane Pintat, Peter Fenici, Niklas Hammar, Linong Ji, Fengming Tang, Eric Wittbrodt, and Filip Surmont. Eligibility of Patients with Type 2 Diabetes for Sodium–glucose Cotransporter 2 Inhibitor Cardiovascular Outcomes Trials: A Global Perspective from the DISCOVER Study. BMJ Publishing Group.

MLA (9th ed.) Citation

Medina, Jesús, et al. Eligibility of Patients with Type 2 Diabetes for Sodium–glucose Cotransporter 2 Inhibitor Cardiovascular Outcomes Trials: A Global Perspective from the DISCOVER Study. BMJ Publishing Group.